TENTH OF RAMADAN PHARMACEUTICAL INDUSTRIES&DIAGNOSTIC-RAMEDATENTH OF RAMADAN PHARMACEUTICAL INDUSTRIES&DIAGNOSTIC-RAMEDATENTH OF RAMADAN PHARMACEUTICAL INDUSTRIES&DIAGNOSTIC-RAMEDA

TENTH OF RAMADAN PHARMACEUTICAL INDUSTRIES&DIAGNOSTIC-RAMEDA

No trades
See on Supercharts

RMDA fundamentals

TENTH OF RAMADAN PHARMACEUTICAL INDUSTRIES&DIAGNOSTIC-RAMEDA financial statements, including revenue, expenses, profit, and loss

The total revenue of RMDA for the last quarter is 545.72 M EGP, and it's 21.16% higher compared to the previous quarter. The net income of Q3 23 is 76.29 M EGP.

Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q2 '23
Q3 '23
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EGP
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q2 '23
Q3 '23
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth